Literature DB >> 31298746

Changing NAFLD Epidemiology in China.

Hye Won Lee1,2,3, Vincent Wai-Sun Wong1,2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31298746     DOI： 10.1002/hep.30848

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning.

Authors:  Cheng Wang; Junbin Yan; Shuo Zhang; Yiwen Xie; Yunmeng Nie; Zhiyun Chen; Sumei Xu
Journal:  Front Med (Lausanne)       Date:  2022-06-09

2.  Inflammatory potential of diet and risk of nonalcoholic fatty liver disease: a prospective cohort study.

Authors:  Shunming Zhang; Ge Meng; Qing Zhang; Li Liu; Hongmei Wu; Yeqing Gu; Yawen Wang; Tingjing Zhang; Xuena Wang; Juanjuan Zhang; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Kun Song; Yaogang Wang; Lu Qi; Kaijun Niu
Journal:  Eur J Clin Nutr       Date:  2022-01-25       Impact factor: 4.884

3.  Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.

Authors:  Feng-Zhi Xin; Ze-Hua Zhao; Rui-Nan Zhang; Qin Pan; Zi-Zhen Gong; Chao Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

Review 4.  Role of Hepatokines in Non-alcoholic Fatty Liver Disease.

Authors:  Yini Ke; Chengfu Xu; Jin Lin; Youming Li
Journal:  J Transl Int Med       Date:  2019-12-31

Review 5.  Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.

Authors:  Qiaoling Wang; Binxia Chang; Xiaoyan Li; Zhengsheng Zou
Journal:  J Clin Transl Hepatol       Date:  2021-01-04

6.  Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.

Authors:  Qian Li; Jia-Xin Tan; Yong He; Fang Bai; Shi-Wei Li; Yi-Wen Hou; Long-Shan Ji; Ya-Ting Gao; Xin Zhang; Zhen-Hua Zhou; Zhuo Yu; Miao Fang; Yue-Qiu Gao; Man Li
Journal:  Int J Biol Sci       Date:  2022-01-31       Impact factor: 6.580

7.  Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.

Authors:  Chen Chen; Caiyun Zhang; Xuelin Wang; Feijuan Zhang; Ze Zhang; Pengchai Ma; Shuzhi Feng
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-07       Impact factor: 2.586

Review 8.  Aldehyde Dehydrogenase, Liver Disease and Cancer.

Authors:  Wenjun Wang; Chunguang Wang; Hongxin Xu; Yanhang Gao
Journal:  Int J Biol Sci       Date:  2020-01-22       Impact factor: 6.580

9.  A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.

Authors:  Xintian Cai; Xiayire Aierken; Ayguzal Ahmat; Yuanyuan Cao; Qing Zhu; Ting Wu; Nanfang Li
Journal:  Biomed Res Int       Date:  2020-11-02       Impact factor: 3.411

10.  Involvement of kindlin-2 in irisin's protection against ischaemia reperfusion-induced liver injury in high-fat diet-fed mice.

Authors:  Jia Zhang; Yifan Ren; Jianbin Bi; Mengzhou Wang; Lin Zhang; Tao Wang; Shasha Wei; Xingyi Mou; Yi Lv; Rongqian Wu
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.295
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.